retour a la liste des nouvelles

Mr. Nathaniel Zoso

Nathaniel has been developing innovative health technologies for the past 11 years. He currently manages the technological and scientific vision of B-Temia. As Chief Technology Officer, he leads the development of the dermoskeletic technology serving human mobility and he puts in place all scientific and technological tools necessary to develop B-Temia’s executive vision further. His focuses are to improve the performance of B-Temia’s products and to establish B-Temia’s roadmap of products and technologies.

Nathaniel started his career developing the algorithms for an automatic titration and weaning of oxygen therapy device, before joining B-Temia in 2011. Nathaniel’s innovative spark and work ethic proved vital to the company’s success, and as such, his role evolved to encompass technology integration, scientific exploration and, eventually to leading B-Temia’s innovation.

Nathaniel is recognized for his ability to always find another point of view to creatively achieve his goals while integrating clinical, technological, and corporate realities. He is eager to build the bridge to the evolution of B-Temia with emerging human-health technologies and welcomes connecting with broad thinkers inside and outside the industry.

Nathaniel holds a Bachelor’s degree in Electronic Engineering (control and servo specialization) from Université Laval and a Master’s degree in Mechanical Engineering (robotics specialization). He was awarded the Canada Millennium Scholarship and the C.D. Howe memorial foundation scholarship. He is now member of the OIQ (Ordre des Ingénieurs du Québec).